Tech

Irish-led biotech firm Synlogic to cease operations after drug trial discontinued

Aoife Brennan, the chief executive at Synlogic Therapeutics, is among those to depart the US-listed company

Aoife Brennan is to step down as chief executive and president of Synlogic Therapeutics after the decision was taken last week to halt trials for a potential treatment for phenylketonuria